Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens, covering 2025-10-22 to 2025-10-22. Get the full timeline:
Most recent: Clinical Trial Update: Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma [Phase 1]